» Articles » PMID: 22875024

Functional Genomics Identifies Drivers of Medulloblastoma Dissemination

Overview
Journal Cancer Res
Specialty Oncology
Date 2012 Aug 10
PMID 22875024
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Medulloblastomas are malignant brain tumors that arise in the cerebellum in children and disseminate via the cerebrospinal fluid to the leptomeningeal spaces of the brain and spinal cord. Challenged by the poor prognosis for patients with metastatic dissemination, pediatric oncologists have developed aggressive treatment protocols, combining surgery, craniospinal radiation, and high-dose chemotherapy, that often cause disabling neurotoxic effects in long-term survivors. Insights into the genetic control of medulloblastoma dissemination have come from transposon insertion mutagenesis studies. Mobilizing the Sleeping Beauty transposon in cerebellar neural progenitor cells caused widespread dissemination of typically nonmetastatic medulloblastomas in Patched(+/-) mice, in which Shh signaling is hyperactive. Candidate metastasis genes were identified by sequencing the insertion sites and then mapping these sequences back to the mouse genome. To determine whether genes located at transposon insertion sites directly caused medulloblastomas to disseminate, we overexpressed candidate genes in Nestin(+) neural progenitors in the cerebella of mice by retroviral transfer in combination with Shh. We show here that ectopic expression of Eras, Lhx1, Ccrk, and Akt shifted the in vivo growth characteristics of Shh-induced medulloblastomas from a localized pattern to a disseminated pattern in which tumor cells seeded the leptomeningeal spaces of the brain and spinal cord.

Citing Articles

Proteomic profiling of cerebrospinal fluid reveals TKT as a potential biomarker for medulloblastoma.

Kim J, Choi S, Dan K, Koh E, Ha S, Phi J Sci Rep. 2024; 14(1):21053.

PMID: 39251709 PMC: 11383936. DOI: 10.1038/s41598-024-71738-z.


Drivers Underlying Metastasis and Relapse in Medulloblastoma and Targeting Strategies.

Holmberg K, Borgenvik A, Zhao M, Giraud G, Swartling F Cancers (Basel). 2024; 16(9).

PMID: 38730706 PMC: 11083189. DOI: 10.3390/cancers16091752.


KMT2D suppresses Sonic hedgehog-driven medulloblastoma progression and metastasis.

Sanghrajka R, Koche R, Medrano H, El Nagar S, Stephen D, Lao Z iScience. 2023; 26(10):107831.

PMID: 37822508 PMC: 10562805. DOI: 10.1016/j.isci.2023.107831.


LHX1 as a potential biomarker regulates EMT induction and cellular behaviors in uterine corpus endometrial carcinoma.

Tian Y, Wen F, Wang S, Lv N Clinics (Sao Paulo). 2022; 77:100103.

PMID: 36116266 PMC: 9489736. DOI: 10.1016/j.clinsp.2022.100103.


ERAS, a Member of the Ras Superfamily, Acts as an Oncoprotein in the Mammary Gland.

Suarez-Cabrera C, Ojeda-Perez I, Sanchez-Baltasar R, Page A, Bravo A, Navarro M Cancers (Basel). 2021; 13(21).

PMID: 34771750 PMC: 8582886. DOI: 10.3390/cancers13215588.


References
1.
Browd S, Kenney A, Gottfried O, Yoon J, Walterhouse D, Pedone C . N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma. Cancer Res. 2006; 66(5):2666-72. DOI: 10.1158/0008-5472.CAN-05-2198. View

2.
Hallahan A, Pritchard J, Hansen S, Benson M, Stoeck J, Hatton B . The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. Cancer Res. 2004; 64(21):7794-800. DOI: 10.1158/0008-5472.CAN-04-1813. View

3.
Northcott P, Korshunov A, Witt H, Hielscher T, Eberhart C, Mack S . Medulloblastoma comprises four distinct molecular variants. J Clin Oncol. 2010; 29(11):1408-14. PMC: 4874239. DOI: 10.1200/JCO.2009.27.4324. View

4.
Dupuy A, Akagi K, Largaespada D, Copeland N, Jenkins N . Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature. 2005; 436(7048):221-6. DOI: 10.1038/nature03691. View

5.
Castellino R, Barwick B, Schniederjan M, Buss M, Becher O, Hambardzumyan D . Heterozygosity for Pten promotes tumorigenesis in a mouse model of medulloblastoma. PLoS One. 2010; 5(5):e10849. PMC: 2877103. DOI: 10.1371/journal.pone.0010849. View